Extreme normovolemic hemodilution: How low can you go and other alternatives to transfusion?

Critical Care Medicine

Volumn 29, Issue 4, 2001, Pages 908-910

  Coursin, D B ^a   Monk, T G ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Blood substitutes; Erythropoietin; Hemodilution; Hemoglobin based oxygen carrying solutions; Normovolemic; Transfusion medicine

Indexed keywords

BLOOD SUBSTITUTE; ERYTHROPOIETIN;

BLOOD SUBSTITUTION; BLOOD TRANSFUSION; BLOOD VOLUME; EDITORIAL; HEMODILUTION; PRIORITY JOURNAL; SUBSTITUTION THERAPY;

EID: 0035046870     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200104000-00051     Document Type: Editorial

References (14)

1. Transfusion medicine
2. Blood transfusion in the ICU: Is there a reason?
3. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis
4. A multicenter, randomized, controlled clinical of transfusion requirements in critical care
5. Blood substitutes: Evolution and future applications
6. Diaspirin crosslinked hemogloin enables extreme hemodilution beyond the critical hematocrit
7. Acute normovolemic hemodilution
8. The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling
9. Immunomodulatory aspects of transfusions
10. -1
11. Profound hemodilution: What is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?
12. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial
13. Randomized trial of diasprin cross-linked hemoglobin solution as an alternative to blood transfusion in cardiac surgery
14. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized double-blind placebo controlled trial